New research has updated our understanding of how sugars, known as glycans, help immune cells move into skin in the ...

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26 ...

ZORYVE foam 0.3% was safe, well-tolerated, and demonstrated durable and continuously improving efficacy in the treatment of seborrheic dermatitis ...

Arctic Bioscience AS ( ($DE:9TD) ) just unveiled an announcement. Arctic Bioscience’s recent analysis from the HeROPA study indicates that their ...

Biologic therapy use among patients with psoriatic disease was associated with a lower risk for malignancy compared with topical therapy use.

The steady approval of new biosimilars in recent years provides additional safe, effective, and cost-effective options for ...

CHICAGO -- Plaque psoriasis drug deucravacitinib (Sotyktu) now looks likely to win a psoriatic arthritis (PsA) indication in ...

A US cohort study shows that coexisting diabetes and psoriasis significantly raise all-cause and cancer mortality risks.

Some people with psoriatic arthritis (PsA) may have a disease that is difficult to manage (D2M) or does not respond to ...

Dandruff doesn't directly cause hair loss, but it can lead to it. Certain conditions that cause flakes and hair loss include ...

Tori Spelling shares her and her family’s journey with eczema and seborrheic dermatitis to encourage others to take control of their skin health ZORYVE® (roflumilast) is the #1 prescribed branded ...